{
    "info": {
        "nct_id": "NCT05644561",
        "official_title": "A Phase 3, Open-label, Single-arm, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants (6 to < 18 Years of Age) With Generalized Myasthenia Gravis (gMG)",
        "inclusion_criteria": "* Diagnosis of gMG confirmed by a positive serologic test for anti-AChR antibodies (Abs) obtained at Screening and/or during Screening Period\n* Myasthenia Gravis Foundation of America (MGFA) Clinical Classification of Class II to Class IV at Screening\n* Participants receiving treatment must be on a stable dosing regimen of adequate duration prior to Screening and during the Screening Period.\n* Eculizumab-experienced participants must have been enrolled and treated with eculizumab in Study ECU-MG-303 for at least 6 months (180 days) and must have been on a stable dose for ≥ 2 months (60 days) prior to Screening.\n* All participants must be vaccinated against meningococcal infection\nHealthy volunteers allowed",
        "exclusion_criteria": "Medical Conditions\n\n* Any untreated thymic malignancy, carcinoma, or thymoma.\n* Participants with a history of treated benign thymoma\n* History of thymectomy, thymomectomy, or any thymic surgery within the 12 months prior to Screening\n* History of N meningitidis infection\n* Known to be human immunodeficiency virus (HIV) positive\n* History of unexplained infections\n* Known or suspected history of drug or alcohol abuse or dependence within 1 year prior to the start of the Screening Period",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Diagnosis of gMG confirmed by a positive serologic test for anti-AChR antibodies (Abs) obtained at Screening and/or during Screening Period",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of gMG confirmed",
                    "criterion": "generalized myasthenia gravis (gMG) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "positive serologic test for anti-AChR antibodies (Abs) obtained at Screening and/or during Screening Period",
                    "criterion": "anti-AChR antibodies (Abs) serologic test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": [
                                "at Screening",
                                "during Screening Period"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants receiving treatment must be on a stable dosing regimen of adequate duration prior to Screening and during the Screening Period.",
            "criterions": [
                {
                    "exact_snippets": "Participants receiving treatment must be on a stable dosing regimen",
                    "criterion": "treatment dosing regimen",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate duration prior to Screening and during the Screening Period",
                    "criterion": "treatment dosing regimen duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": "adequate duration prior to Screening and during the Screening Period"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eculizumab-experienced participants must have been enrolled and treated with eculizumab in Study ECU-MG-303 for at least 6 months (180 days) and must have been on a stable dose for ≥ 2 months (60 days) prior to Screening.",
            "criterions": [
                {
                    "exact_snippets": "Eculizumab-experienced participants must have been enrolled and treated with eculizumab in Study ECU-MG-303 for at least 6 months (180 days)",
                    "criterion": "enrollment and treatment with eculizumab in Study ECU-MG-303",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 180,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "must have been on a stable dose for ≥ 2 months (60 days) prior to Screening",
                    "criterion": "stable dose of eculizumab",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* All participants must be vaccinated against meningococcal infection",
            "criterions": [
                {
                    "exact_snippets": "vaccinated against meningococcal infection",
                    "criterion": "meningococcal infection vaccination",
                    "requirements": [
                        {
                            "requirement_type": "vaccination_status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Myasthenia Gravis Foundation of America (MGFA) Clinical Classification of Class II to Class IV at Screening",
            "criterions": [
                {
                    "exact_snippets": "Myasthenia Gravis Foundation of America (MGFA) Clinical Classification of Class II to Class IV at Screening",
                    "criterion": "MGFA Clinical Classification",
                    "requirements": [
                        {
                            "requirement_type": "classification_range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "Class"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "Class"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Participants with a history of treated benign thymoma",
            "criterions": [
                {
                    "exact_snippets": "history of treated benign thymoma",
                    "criterion": "benign thymoma",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": "treated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of N meningitidis infection",
            "criterions": [
                {
                    "exact_snippets": "History of N meningitidis infection",
                    "criterion": "N meningitidis infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known or suspected history of drug or alcohol abuse or dependence within 1 year prior to the start of the Screening Period",
            "criterions": [
                {
                    "exact_snippets": "Known or suspected history of drug ... abuse or dependence within 1 year prior to the start of the Screening Period",
                    "criterion": "drug abuse or dependence",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Known or suspected history of ... alcohol abuse or dependence within 1 year prior to the start of the Screening Period",
                    "criterion": "alcohol abuse or dependence",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of unexplained infections",
            "criterions": [
                {
                    "exact_snippets": "History of unexplained infections",
                    "criterion": "unexplained infections",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known to be human immunodeficiency virus (HIV) positive",
            "criterions": [
                {
                    "exact_snippets": "Known to be human immunodeficiency virus (HIV) positive",
                    "criterion": "HIV status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any untreated thymic malignancy, carcinoma, or thymoma.",
            "criterions": [
                {
                    "exact_snippets": "Any untreated thymic malignancy",
                    "criterion": "thymic malignancy",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        }
                    ]
                },
                {
                    "exact_snippets": "carcinoma",
                    "criterion": "carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        }
                    ]
                },
                {
                    "exact_snippets": "thymoma",
                    "criterion": "thymoma",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of thymectomy, thymomectomy, or any thymic surgery within the 12 months prior to Screening",
            "criterions": [
                {
                    "exact_snippets": "History of thymectomy, thymomectomy, or any thymic surgery within the 12 months prior to Screening",
                    "criterion": "history of thymic surgery",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months prior to Screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Medical Conditions",
            "criterions": [
                {
                    "exact_snippets": "Medical Conditions",
                    "criterion": "medical conditions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}